HHS

Linscott Brian

Known title: Chief Executive OfficerCIK: 0001807291

Linscott Brian's purchase track record

How the stock did after each of Linscott Brian's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
8
of 8 since November 15, 2021
Stock higher 6 months later
50%
3 months: 38%
Median 6-month return
+7.3%
3 months: -14.4%
Beat the S&P 500
63%
median +13.3% vs. index
PurchaseStockAmount3 months6 months
5/24/2023HHS$28K+17.1%+23.7%
5/8/2023HHS$48K+0.5%+19.0%
3/15/2023HHS$22K-28.9%-28.6%
12/12/2022HHS$28K-14.9%-43.3%
8/15/2022HHS$30K-28.4%-24.4%
2/28/2022HHS$223K+38.5%+138.7%
12/1/2021HHS$32K-13.9%+15.1%
11/15/2021HHS$42K-20.0%-0.6%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

this person other insiders at HHS

Transaction History

HHS▼ Sell$9K
HHS▲ Buy$27K
HHS▲ Buy$562
HHS▲ Buy$48K
HHS▼ Sell$93K
HHS▲ Buy$22K
HHS▲ Buy$22K
HHS▲ Buy$6K
HHS▼ Sell$317K
HHS▲ Buy$30K
HHS▼ Sell$77K
HHS▼ Sell$52K
HHS▲ Buy$66K
HHS▲ Buy$33K
HHS▲ Buy$33K
HHS▲ Buy$92K
HHS▲ Buy$71K
HHS▲ Buy$800
HHS▲ Buy$2K
HHS▲ Buy$727
HHS▲ Buy$795
HHS▲ Buy$28K
HHS▲ Buy$42K
HHS▲ Buy$20K
HHS▲ Buy$7K

We use analytics to understand how market-wall is used. No personal data is sold.